Volume 11 Supplement 1
OR6-005 – Cystine crystals activate inflammasomes
© Prencipe et al; licensee BioMed Central Ltd. 2013
Published: 8 November 2013
Nephropathic cystinosis is a rare autosomal recessive disorder caused by a mutation in the CTNS gene, which encodes for cystinosin. It is characterized by the lysosomal accumulation of cystine, which leads to the formation of cystine crystals within various organs, including kidneys, brain, cornea, intestine and bone marrow. The exact role of intralysosomal cystine crystals accumulation in the pathogenesis of clinical features of cystinosis is still unclear, although it is well known that cystine levels are directly proportional to disease severity.
In this study, we investigate whether cystine crystals are able to elicit inflammasome activation.
Primary human peripheral blood mononuclear cells (PBMCs) were cultured in vitro, pre-incubated with LPS, stimulated with L-cystine crystals in presence or absence of different inhibitors and the IL-1beta (IL-1b) released in the medium was measured by ELISA.
LPS-primed PBMCs stimulated with L-cystine crystals secreted IL-1b in a dose-dependent manner. Similarly to other NLRP3-activating particles, cystine crystal-induced IL-1b secretion was caspase-1-dependent. Indeed, when PBMCs were pre-icubated with the specific CASP-1 inhibitor (Z-YVAD-fmk), a dramatic decrease in IL-1β production was observed, suggesting the involvement of an inflammasome-mediated pathway. By confocal microscopy, we observed that exogenous L-cystine crystals were internalized by monocytic/macrophagic adherent cells. Inhibition of actin polymerization with cytochalasin D effectively blocked cystine crystal-induced IL-1β secretion, showing that phagocytosis is necessary for this effect.
Taken together, these data demonstrate that cystine crystals represent a new endogenous inflammasome activating danger signal, suggesting a new role for cystine crystals in the pathogenesis of nephropathic cystinosis.
Disclosure of interest
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.